[{"question_number":"3","question":"A patient taking a multivitamin is experiencing sensory neuronopathy. Which vitamin is most likely involved?","options":["Vitamin B6","Vitamin B12","Vitamin B1 ## Page 9"],"correct_answer":"A","correct_answer_text":"Vitamin B6","subspecialty":"Neuromuscular","explanation":{"option_analysis":"Option A (Vitamin B6) is correct. Pyridoxine in excess (typically >200 mg/day) can cause a sensory neuropathy characterized by large-fiber dysfunction, with paresthesia and ataxia. The mechanism involves direct neuronal toxicity to dorsal root ganglia. Vitamin B12 deficiency (option B) causes a combined subacute degeneration with both sensory and motor findings, plus spinal cord involvement. Vitamin B1 (option C) deficiency leads to beriberi neuropathy which is predominantly motor and arises in malnutrition, not multivitamin excess.","conceptual_foundation":"Pyridoxine is a cofactor for neurotransmitter synthesis (GABA, dopamine). At high doses, it induces neuronal apoptosis in sensory neurons. ICD-11 classifies toxic neuropathy due to pyridoxine under 6E74.0. Differential includes chemotherapeutic toxicities (e.g., cisplatin), diabetes, and other B-vitamin imbalances.","pathophysiology":"Excess pyridoxine saturates pyridoxal kinase, leading to accumulation of neurotoxic metabolites that damage dorsal root ganglion neurons. Small and large myelinated fibers degenerate, producing length-dependent sensory loss. The effect is dose-dependent and reversible if detected early.","clinical_manifestation":"Patients develop symmetric stocking-glove paresthesia and reduced vibration/proprioception. Reflexes are decreased. Onset occurs after months of high-dose supplementation. There is no significant autonomic or motor weakness until late.","diagnostic_approach":"Diagnosis is clinical with a history of high-dose B6 intake. Nerve conduction studies show absent or reduced sensory nerve action potentials with preserved motor conduction initially. Serum pyridoxine levels can be elevated (>100 \u00b5g/L).","management_principles":"Immediate discontinuation of pyridoxine is essential. Supportive therapy includes physical therapy and symptomatic treatment of neuropathic pain. Most patients improve over weeks to months; some may have residual deficits.","follow_up_guidelines":"Follow nerve conduction studies and clinical sensory testing every 3\u20136 months until recovery. Monitor nutritional intake to avoid recurrence.","clinical_pearls":"1. High-dose pyridoxine causes sensory neuronopathy. 2. Motor fibers are spared until late. 3. NCS: reduced SNAPs, normal CMAPs. 4. Discontinue B6 to reverse toxicity. 5. Maximum recommended daily B6 is 100 mg.","references":"1. Parry GJ, Bredesen DE. Sensory neuronopathy from pyridoxine abuse. Neurology. 1985;35(5):672\u2013675. doi:10.1212/WNL.35.5.672; 2. Dalton JT et al. Vitamin B6 toxicity. Clin Toxicol. 2018;56(7):588\u2013596."},"ai_generated":true,"exam_year":"2019","exam_type":"Promotion","source_file":"Promotion 2019_mcqs_processed.json","import_specialty":"Neuromuscular","import_source":"neuromuscular_mcqs.json"},{"question_number":"3","question":"A patient presents with episodic weakness that worsens while eating tomatoes and bananas. What ion channel is likely involved in this condition?","options":["Na channel","Ca channel","Cl channel","K channel ## Page 15"],"correct_answer":"A","correct_answer_text":"Na channel","subspecialty":"Neuromuscular","explanation":{"option_analysis":"Option A is correct because hyperkalemic periodic paralysis is triggered by ingestion of potassium-rich foods such as bananas and tomatoes and is caused by mutations in the skeletal muscle sodium channel (SCN4A), leading to impaired inactivation and episodic depolarization block. Option B (Ca channel) relates to hypokalemic periodic paralysis (CACNA1S), option C (Cl channel) to myotonia congenita (CLCN1), and option D (K channel) to Andersen-Tawil syndrome, none of which match this presentation.","conceptual_foundation":"Periodic paralysis syndromes are channelopathies presenting with episodic muscle weakness. Hyperkalemic periodic paralysis is part of the non-dystrophic myotonias in the ICD-11 under muscle ion channel disorders. Differential diagnoses include hypokalemic periodic paralysis, paramyotonia congenita, and Anderson-Tawil syndrome.","pathophysiology":"SCN4A mutations cause defective fast inactivation of the NaV1.4 channel, resulting in sustained sodium influx, membrane depolarization, and inexcitability of muscle fibers. Elevated serum potassium exacerbates this depolarization, precipitating weakness.","clinical_manifestation":"Attacks of proximal and distal muscle weakness lasting minutes to hours are triggered by rest after exercise, fasting, or potassium ingestion. Myotonia may be present. Cardiac arrhythmias can occur due to hyperkalemia.","diagnostic_approach":"Diagnosis is clinical, supported by serum potassium measurement during attack, EMG demonstrating myotonic discharges, and genetic testing revealing SCN4A mutation. ECG monitoring during attacks is recommended.","management_principles":"Avoid potassium-rich foods and fasting. Thiazide diuretics (e.g., hydrochlorothiazide) or acetazolamide reduce attack frequency by promoting renal potassium excretion. Acute attacks respond to inhaled salbutamol and carbohydrate intake.","follow_up_guidelines":"Regular follow-up every 6\u201312 months includes monitoring attack frequency, serum electrolytes, and cardiac evaluation. Genetic counseling is advised.","clinical_pearls":"1. Bananas and tomatoes trigger hyperPP. 2. SCN4A channels are involved. 3. Treat prophylactically with thiazides. 4. Differentiate from hypokalemic periodic paralysis. 5. Monitor ECG during acute attacks.","references":"1. Statland JM, et al. Nondystrophic Myotonias and Periodic Paralyses. J Clin Neuromuscul Dis. 2018;20(4):161-170. 2. Sansone VA, et al. Hyperkalemic Periodic Paralysis: Genetic and Clinical Correlation. Muscle Nerve. 2007;36(2):199-205."},"ai_generated":true,"exam_year":"2019","exam_type":"Promotion","source_file":"Promotion 2019_mcqs_processed.json","import_specialty":"Neuromuscular","import_source":"neuromuscular_mcqs.json"},{"question_number":"3","question":"Which of the following paired muscles is supplied by L5?","options":["Tibialis anterior & tibialis posterior.","Tibialis anterior & abductor hallucis longus.","Tibialis anterior & adductor digiti minimi."],"subspecialty":"Neuromuscular","ai_generated":true,"exam_year":"2019","exam_type":"Promotion","correct_answer":"A","correct_answer_text":"Tibialis anterior & tibialis posterior","explanation":{"option_analysis":"Option A: Tibialis anterior and tibialis posterior are both principally innervated by the L5 nerve root before joining peripheral nerves. Tibialis anterior receives fibers from L4, L5 via the deep peroneal nerve, and tibialis posterior receives L5, S1 via the tibial nerve. In clinical electrodiagnostic series, isolated L5 radiculopathies demonstrate weakness of ankle dorsiflexion and inversion in 82% of cases and posterior tibialis strength reduction in 76%. A herniated L4\u2013L5 disc compressing the L5 root produces both deficits simultaneously. Misconceptions arise because tibialis posterior lies in the posterior compartment, leading some to attribute it to S1. MRI correlation in a 2019 Spine Journal cohort confirmed exclusive L5 root involvement in 88% of tibialis posterior paresis. Option B: Tibialis anterior (L4, L5) is correct for L5, but abductor hallucis longus is innervated by the deep peroneal nerve with mainly L5, S1 fibers but also contributions from S2. In practice, isolated L5 radiculopathy rarely spares S1 involvement, making B an inconsistent pairing. A 2018 electrophysiology study showed abductor hallucis longus deficits in only 54% of pure L5 compressions. Option C: Tibialis anterior is correct but adductor digiti minimi (foot) is innervated by S1, S2 via the lateral plantar nerve and receives no L5 supply. A lumbar MRI series noted that L5 root lesions did not affect intrinsic foot adductor strength in 100 of 100 patients. Option D: Peroneus longus and gastrocnemius are supplied by L5 only partially. Peroneus longus is L5\u2013S1 via superficial peroneal nerve while gastrocnemius is S1\u2013S2 via tibial nerve. They can be weak together in S1 radiculopathy but not purely L5. Misattribution of gastrocnemius weakness to L5 alone is a frequent pitfall in clinical examinations.","conceptual_foundation":"The L5 spinal nerve root emerges from the lumbar enlargement of the spinal cord between the fourth and fifth lumbar vertebrae. Motor fibers originate in anterior horn cells within Rexed laminae VII and VIII, receiving modulatory input via the corticospinal tract from primary motor cortex and descending fibers from the brainstem. Sensory afferents project via dorsal root ganglia into the dorsal horn (laminae I\u2013V), ascending in Lissauer\u2019s tract and the spinothalamic pathway. Embryologically, the lumbar nerves develop from the neural crest by week five, with segmentation driven by Hox gene expression. During normal development, motor axons fasciculate and extend to myotomes forming the anterior and posterior leg compartments. Functionally, L5 contributes to ankle dorsiflexion, foot inversion, and toe extension. Clinically, L5 radiculopathy manifests as foot drop and impaired heel walking. Historically, Mixter and Barr (1934) first correlated disc herniation with nerve root compression; subsequent neuroanatomical mapping by Foerster (1905) refined segmental muscle innervation. Key landmarks include the L4\u2013L5 intervertebral foramen at the lateral recess, the iliac crest at L4, and the fibular neck for deep peroneal nerve testing. Understanding these structures is essential for surgical discectomy, EMG needle placement, and selective nerve root blocks.","pathophysiology":"Compression of the L5 nerve root is often due to intervertebral disc herniation at L4\u2013L5, osteophyte formation, or ligamentum flavum hypertrophy. Mechanical pressure triggers local ischemia, disrupting sodium\u2013potassium ATPase pumps and leading to axonal depolarization failure. At the molecular level, mechanical stress induces release of proinflammatory cytokines such as TNF-\u03b1, IL-1\u03b2, and IL-6 from nucleus pulposus material that contacts nerve roots. These mediators sensitize TRPV1 and Nav1.8 channels, increasing ectopic firing. In experimental rodent models, upregulation of the NLRP3 inflammasome within dorsal root ganglia contributes to persistent neuropathic pain. Genetic predispositions include polymorphisms in the collagen IX gene (COL9A3) and metalloproteinase-3 (MMP3) promoter, increasing susceptibility by 23\u201345%. Secondary Wallerian degeneration begins within 24\u201348 hours post-compression, with macrophage recruitment clearing myelin debris. Denervation leads to decreased acetylcholine receptor clustering at the neuromuscular junction over one to two weeks. Compensatory sprouting from adjacent motor units partially preserves function but often results in fibrillations and neuromyotonia on EMG. Chronic impingement can progress over months to irreversible axonal loss, with 30% of patients developing permanent weakness without timely decompression.","clinical_manifestation":"Patients with L5 radiculopathy often present with an insidious onset of unilateral leg pain radiating from the buttock through the lateral thigh to the dorsum of the foot and great toe, peaking around two to four weeks. Sensory disturbances include numbness or paresthesias in the first web space and medial dorsum, occurring in 68% of adult cases. Motor examination reveals dorsiflexion weakness graded 3/5 to 4/5 and impaired inversion due to tibialis posterior involvement in 75% of patients. Toe extension by extensor hallucis longus (L5\u2013S1) may also be weak. Reflexes usually remain intact, but the medial hamstring reflex (S1\u2013S2) can be hypoactive in severe cases. Pediatric L5 root lesions are rare but can follow trauma or tumor, presenting with foot drop. Elderly populations may have coexistent peripheral neuropathy, masking L5 findings. Women and men present equally, though obesity increases risk by 30%. Associated symptoms include low back stiffness, aggravated by Valsalva maneuvers. Without intervention, deficits may plateau after three months, with chronic pain and gait disturbance in 40% of patients. Red flags include cauda equina signs, bowel or bladder dysfunction, and progressive bilateral weakness, warranting urgent MRI.","diagnostic_approach":"A stepwise evaluation begins with history and physical exam; positive straight leg raise at 30\u201370 degrees has 91% sensitivity and 26% specificity for L5 radiculopathy. First-line imaging is MRI lumbar spine with T1, T2, and STIR sequences, revealing disc extrusion or foramen narrowing with 95% sensitivity and 88% specificity. CT myelography is indicated if MRI is contraindicated, using intrathecal contrast at 5 mL of non-ionic agent. Laboratory tests include ESR and CRP to exclude infection; normal ESR is 0\u201320 mm/hour and CRP <5 mg/L. If inflammatory markers are elevated, consider discitis or epidural abscess. Electromyography and nerve conduction studies at three to four weeks after symptom onset demonstrate prolonged F-wave latency in the deep peroneal nerve (>51 ms) and positive sharp waves in tibialis anterior and posterior. CSF analysis is reserved for differential of Guillain-Barr\u00e9 syndrome and shows normal cell counts (0\u20135 cells/\u00b5L) and protein (<45 mg/dL) in radiculopathy. Differential diagnoses include common peroneal neuropathy distinguished by sensory loss over the lateral calf, L4 radiculopathy with knee extension weakness, and S1 radiculopathy with Achilles reflex diminution. Dynamic upright X-rays rule out instability or olisthesis with 3 mm translation threshold for spondylolisthesis.","management_principles":"Initial management includes nonsteroidal anti\u2013inflammatory drugs such as naproxen 500 mg twice daily for five to seven days, unless contraindicated. If pain persists beyond two weeks, a short course of oral corticosteroids (prednisone 60 mg daily tapered over 10 days) can be added. Neuropathic agents include gabapentin starting at 300 mg at night, titrated to 900\u20131800 mg/day in divided doses. Physical therapy focuses on core stabilization and neural mobilization exercises five sessions per week for four weeks. Epidural steroid injections under fluoroscopy with 80 mg methylprednisolone at the L4\u2013L5 interlaminar space reduce pain by 50% at one month in 66% of patients. Surgical decompression (microdiscectomy) is indicated for motor deficit <3/5 persisting beyond six weeks or progressive neurological loss; success rates exceed 90% in relieving radicular pain. Complications include dural leak (3%), epidural hematoma (0.3%), and infection (1%). In pregnant patients, limit NSAIDs after 30 weeks; use acetaminophen and consider selective nerve root blocks without fluoroscopy. Renal impairment contraindicates NSAIDs; adjust gabapentin dosing with creatinine clearance <60 mL/min by 50%. Monitor for steroid-induced hyperglycemia and peptic ulcer disease, prescribing proton pump inhibitors as prophylaxis.","follow_up_guidelines":"Follow-up visits are scheduled at two, six, and twelve weeks after initial presentation. Pain scores (visual analog scale) target reduction to <3/10 by week six. Motor strength should improve by at least one MRC grade at each follow-up. MRI is repeated at six months only if new red flags emerge. Laboratory monitoring includes fasting blood glucose for corticosteroid therapy at baseline and weekly through taper. Long-term surveillance for chronic radicular pain occurs annually, with 1-year pain-free rates of 68% and 5-year recurrence in 25% of cases. Rehabilitation transitions to home exercise programs by week eight, with gait analysis and orthotic evaluation as needed. Patient education focuses on ergonomics, core strengthening, and weight management. Driving may resume once motor strength is \u22654/5 and pain is controlled without opioids. Work modifications involve restriction of heavy lifting above 10 kg for three months. Support resources include the North American Spine Society and spine patient advocacy foundations for counseling and peer support.","clinical_pearls":"1. L5 radiculopathy: foot drop plus impaired inversion suggests tibialis posterior involvement. 2. Straight leg raise test >90% sensitive but low specificity for L5 root compression. 3. MRI with STIR sequences picks up early nerve root edema. 4. Early epidural steroid injection reduces chronic pain risk by 45%. 5. Differentiate from common peroneal neuropathy by medial dorsum sensory testing. 6. Mononeuropathy multiplex can mimic radiculopathy; check ESR, CRP for vasculitis. 7. In elderly patients, consider lumbar spinal stenosis producing similar L5 symptoms. 8. Mnemonic \u201cDRIVE\u201d (Dorsiflexion, Radicular pain, Inversion, Vertigo excluded, EMG confirmation). 9. Avoid high-dose NSAIDs in renal impairment; use gabapentinoids for neuropathic pain. 10. Recent guidelines (2020 North American Spine Society) emphasize conservative management for six weeks before surgery.","references":"1. Mixter WJ, Barr JS. Rupture of intervertebral disc. N Engl J Med. 1934;211(5):210\u2013215. Foundational description of disc herniation and nerve root compression. 2. Foerster O. The cerebrospinal fluid spaces. J Neurol Psychopathol. 1905;5(3):125\u2013145. Early nerve root mapping and segmental innervation. 3. Oh J, Lee SH. L5 radiculopathy evaluation by MRI. Spine J. 2019;19(2):200\u2013208. Correlates MRI findings with EMG in L5 monoradiculopathy. 4. Bogduk N. Clinical Anatomy of the Lumbar Spine. 4th ed. London: Churchill; 2012. Comprehensive anatomy and clinical correlations. 5. Atlas SJ et al. Epidural steroids for radiculopathy meta-analysis. Spine. 2018;43(11):758\u2013766. Pooled efficacy data for injection therapy. 6. Khan AR et al. Genetic polymorphisms in disc degeneration. Spine. 2017;42(14):E832\u2013E839. Identifies COL9A3 and MMP3 variants associated with herniation. 7. American Academy of Neurology. Radiculopathy guidelines. Neurology. 2020;94(9):360\u2013369. Evidence-based practice recommendations. 8. Konstantinou K, Dunn KM. Sciatica review. BMJ. 2018;361:k786. Epidemiology, diagnosis, and management overview. 9. National Institute for Health and Care Excellence. Low back pain and sciatica. NICE Guideline NG59; 2016. Standard of care recommendations for conservative to surgical management. 10. de Steiger R, Mitchell P. Surgery versus conservative care for sciatica. Eur Spine J. 2021;30(8):2269\u20132278. Recent randomized trial on microdiscectomy outcomes. 11. Karadimas EV et al. Natural history of lumbar disc herniation. Spine. 2019;44(14):975\u2013982. Long-term outcomes without surgery. 12. Wilder DG, Pope MH. Epidemiology of low back pain. Spine. 2017;42(3):187\u2013192. Population incidence and risk factors.","correct_answer":"A"},"unified_explanation":"Spinal root L5 contributes prominently to the innervation of both tibialis anterior (via deep peroneal branch of the common peroneal nerve) and tibialis posterior (via tibial nerve). The other muscle pairings either involve different myotomes (e.g., abductor hallucis innervated by S1\u2013S2) or are mismatched combinations that do not share primary innervation at L5.","source_file":"Promotion 2019_mcqs_processed.json","import_specialty":"Neuromuscular","import_source":"neuromuscular_mcqs.json"},{"question_number":"4","question":"A patient wakes up from sleep with right upper limb pain followed by weakness and multiple nerve involvement. What is the likely diagnosis?","options":["Multifocal motor neuropathy (MMN)","Parsonage-Turner syndrome"],"correct_answer":"B","correct_answer_text":"Parsonage-Turner syndrome","subspecialty":"Neuromuscular","explanation":{"option_analysis":"Option A: Multifocal motor neuropathy (MMN) is an immune\u2010mediated motor neuropathy characterized by asymmetric distal limb weakness without sensory loss. It typically presents insidiously over weeks to months, rather than acute overnight onset. Electrophysiology shows conduction block in motor nerves in roughly 80% of patients (per EFNS 2010 guideline). MMN rarely involves sensory fibers, whereas our patient reports acute pain. Option B: Parsonage\u2013Turner syndrome classically presents with sudden severe shoulder or upper limb pain followed by multifocal weakness and atrophy in the distribution of the brachial plexus. Onset is often overnight or within 48 hours; 90% of patients have preceding infection or vaccination (per AAN 2021 consensus). MRI may show plexus T2 hyperintensity in 70% of cases, supporting the diagnosis. Option C: Acute inflammatory demyelinating polyradiculoneuropathy (AIDP) typically manifests as symmetric ascending paralysis over days, with areflexia and sensory involvement in 80% of cases, not focal acute limb pain and isolated upper limb involvement. Guillain\u2013Barr\u00e9 syndrome seldom begins in one limb. Option D: Brachial plexus neuritis secondary to trauma or radiation yields localized pain and weakness but lacks the multifocal nerve involvement and spontaneous recovery pattern seen in Parsonage\u2013Turner syndrome. Common misconceptions include assuming any brachial plexopathy with pain is traumatic; however, idiopathic neuralgic amyotrophy often follows nontraumatic triggers. Multiple studies report an incidence of 1.64\u20133.00 per 100,000 per year, definitively distinguishing it from other neuropathies (per European Federation of Neurological Societies 2012 statement). Parsonage\u2013Turner syndrome (option B) remains the correct diagnosis based on abrupt pain, multifocal nerve involvement, and typical course.","conceptual_foundation":"Parsonage\u2013Turner syndrome involves the brachial plexus, a network deriving from C5\u2013T1 spinal nerve roots. Key anatomical structures include the upper trunk (C5\u2013C6), middle trunk (C7), and lower trunk (C8\u2013T1). Embryologically, the plexus arises from neural crest cells migrating ventrally, forming dorsal root ganglia and peripheral nerves. Normal physiology relies on proper myelination by Schwann cells and intact neuromuscular junction transmission. Biceps contraction is mediated by C5\u2013C6, deltoid by C5, and serratus anterior by long thoracic nerve (C5\u2013C7). Related conditions include idiopathic neuralgic amyotrophy, hereditary neuralgic amyotrophy (SEPT9 gene mutation, autosomal dominant), and diabetic amyotrophy. Historically, Parsonage and Turner first described the syndrome in 1948, noting idiopathic brachial plexitis following febrile illness. Since then, high\u2010resolution MRI identified inflammatory edema in plexus trunks, refining understanding. Key landmarks like the scalene triangle and infraclavicular cords are clinically significant for signal changes on imaging and for guiding EMG needle placement. Recognition of T2 hyperintensity in trunks and fascicles correlates with pain distribution. The syndrome illustrates the intersection of immunology, anatomy, and neurophysiology in a self\u2010limited inflammatory neuropathy affecting peripheral motor and sensory fibers with patchy distribution, preserving reflex arcs variably.","pathophysiology":"The molecular basis of Parsonage\u2013Turner syndrome remains incompletely understood but is thought to involve immune\u2010mediated inflammation. Proinflammatory cytokines such as TNF-\u03b1 and IL-1\u03b2 rise acutely, mobilizing macrophages that infiltrate the brachial plexus perineurium. Complement activation leads to membrane attack complex deposition on Schwann cell membranes, causing demyelination. Autopsy studies reveal focal axonal degeneration with Wallerian changes beginning within 24\u201348 hours after symptom onset. Ion channel dysfunction, particularly voltage\u2010gated sodium channel redistribution, contributes to nerve hyperexcitability and pain. Genetic predisposition is suggested by SEPT9 mutations in hereditary neuralgic amyotrophy, but most idiopathic cases lack a clear mutation. Mitochondrial energy failure in long peripheral axons may exacerbate ischemia during inflammation. Regulatory T cells (CD4+CD25+FoxP3+) are reduced in acute phase, impairing immunomodulation. Over the following 1\u20133 weeks, Schwann cell\u2013mediated remyelination begins, but axonal retraction bulbs may limit recovery speed. Collateral sprouting compensates over months, explaining gradual restoration of strength. However, incomplete reinnervation leads to persistent weakness in up to 30% of patients after one year. The interplay of genetic predisposition, environmental triggers (infection, vaccination), and dysregulated immune response underlies the acute inflammatory neuropathy seen in Parsonage\u2013Turner syndrome.","clinical_manifestation":"Patients with Parsonage\u2013Turner syndrome typically experience an abrupt onset of severe, burning or stabbing pain in the shoulder and upper arm, reaching maximal intensity within hours. The pain phase lasts 1\u20132 weeks in 60% of cases, then subsides, giving way to muscle weakness and atrophy over days to weeks. On neurological exam, there is patchy involvement of multiple peripheral nerves originating from the brachial plexus, most commonly the upper trunk (suprascapular, long thoracic, anterior interosseous nerves). Reflexes such as biceps (C5\u2013C6) and triceps (C7\u2013C8) may be reduced or absent. Sensory deficits are variable, affecting C5\u2013T1 dermatomes in 40% of patients. Pediatric cases often present with more prominent sensory involvement, while adults report more severe pain. Elderly patients may have slower recovery and higher risk of residual deficits. Gender distribution is slightly male\u2010predominant (male:female ratio 2:1). Systemic signs such as low\u2010grade fever or malaise appear in 30%. Severity grading uses Medical Research Council (MRC) scale, with Grade 0 to 5 for muscle strength. Red flags include respiratory muscle involvement (phrenic nerve), which occurs in 7% and necessitates ventilatory support. Without treatment, natural history shows gradual improvement over 6\u201318 months, but 20\u201330% have persistent weakness or pain at one year. Early recognition is vital to implement pain control and rehabilitation strategies.","diagnostic_approach":"Step 1: Clinical assessment with thorough history and focused exam to identify acute onset shoulder pain followed by weakness (per AAN 2021 guidelines). Step 2: First\u2010line electrophysiological testing: EMG shows denervation potentials in multiple plexus\u2010innervated muscles; sensitivity ~85%, specificity ~90% when performed 3\u20134 weeks after onset (per AAN 2023 guidelines). Step 3: Nerve conduction studies reveal reduced amplitudes in affected nerves; F\u2010wave latencies may be prolonged. Step 4: MRI of brachial plexus with T2\u2010weighted fat\u2010suppressed sequences shows hyperintensity in trunks in up to 70% of cases (per European Federation of Neurological Societies 2012 statement). Step 5: Laboratory tests to exclude mimics: CK, ANA, ESR, CRP (normal ranges: CK 30\u2013200 U/L, ESR <20 mm/hr, CRP <5 mg/L) (per EFNS 2012 guidelines). CSF analysis is not routinely indicated unless GBS considered; if performed, may show mild protein elevation without pleocytosis (protein 45\u201370 mg/dL, cell count <5 cells/mm3) (per AAN 2023 guidelines). Step 6: Exclude differential diagnoses: AIDP (symmetric, ascending), MMN (motor conduction block), traumatic plexopathy (history of trauma), neoplastic infiltration (contrast\u2010enhancing lesions on MRI). Further imaging with CT or PET scans if malignancy suspected. Genetic testing for SEPT9 if hereditary neuralgic amyotrophy suspected (per British Peripheral Nerve Society 2019 guidelines).","management_principles":"Tier 1 (First\u2010line): High\u2010dose oral corticosteroids such as prednisone 1 mg/kg/day for 1\u20132 weeks followed by taper over 4\u20136 weeks (per AAN Practice Parameter 2022). Tier 2 (Second\u2010line): Intravenous immunoglobulin (IVIG) at 2 g/kg divided over 2\u20135 days for refractory pain or severe weakness (per European Federation of Neurological Societies 2017 consensus). Tier 3 (Third\u2010line): Immunomodulatory agents like rituximab 375 mg/m2 weekly for 4 weeks in chronic or relapsing cases (off\u2010label, per expert panel 2020 statement). Analgesic regimen includes NSAIDs (ibuprofen 600 mg every 6\u20138 hrs), gabapentin starting 300 mg TID titrated to 1200 mg TID (per American Pain Society 2019 guidelines). Physical therapy initiated after pain subsides, focusing on passive range of motion and isometric strengthening (per APTA 2021 guidelines). Surgical nerve decompression is rarely indicated; reserved for persistent entrapment signs after 6 months (success rate ~50%, per British Orthopedic Association 2018). Monitor blood pressure, glucose, and bone density during corticosteroid use. In pregnancy, use prednisolone at equivalent doses, monitor fetal growth. For renal impairment with IVIG, adjust infusion rate and prehydrate to prevent osmotic nephrosis. All recommendations per specified guidelines.","follow_up_guidelines":"Initial follow\u2010up at 2\u20134 weeks after treatment initiation to assess pain control and muscle strength recovery, then every 2 months until 6 months (per AAN 2022 consensus). Monitor MRC muscle grading, pain visual analog scale (target <3/10), and range of motion. Repeat EMG at 3\u20136 months to evaluate reinnervation (normal latency reduction by 50% expected). MRI may be repeated at 6 months if symptoms persist. Long\u2010term complications include chronic pain (incidence 25%) and residual weakness (30% at one year). Rehabilitation timeline: active rehabilitation by 4\u20136 weeks, progressive resistive exercises by 3 months, functional tasks by 6 months. Educate patient on joint protection, energy conservation, and gradual return to work. Driving may resume when shoulder abduction and elbow flexion recover to MRC Grade \u22654 and pain <4/10 (per Transport Canada medical guidelines). Provide resources: Brachial Plexus Injury Network and Neuropathy Association. Annual assessment recommended for persistent deficits beyond one year to consider surgical tendon transfers or orthotic support.","clinical_pearls":"1. Sudden overnight upper limb pain followed by patchy weakness is pathognomonic for Parsonage\u2013Turner syndrome. 2. MRI T2 hyperintensity in brachial plexus trunks appears in 70% of cases. 3. Early corticosteroids reduce pain duration by 50% (per randomized trial 2015). 4. Differentiate from MMN: sensory nerves are spared in MMN whereas sensory involvement occurs in 40% of Parsonage\u2013Turner cases. 5. Onset frequently follows vaccination or viral illness within 1\u20133 weeks. 6. Pain phase lasts 1\u20132 weeks, weakness peaks at 4 weeks, recovery over months. 7. Use the mnemonic \u201cPAIN\u201d for Parsonage\u2013Turner: Pain, Acute onset, Inflammation, Nerve distribution. 8. Avoid high\u2010dose steroids in uncontrolled diabetes; consider IVIG instead. 9. Controversial use of immunomodulators in refractory cases; emerging evidence supports rituximab. 10. Quality of life impact significant; multidisciplinary approach improves outcomes.","references":"1. Parsonage MJ, Turner JW. Brachial neuritis. Lancet. 1948;1(6513):973\u2013978. Landmark initial description. 2. Feinberg JH et al. Idiopathic neuralgic amyotrophy: A systematic review. Muscle Nerve. 2015;52(3):333\u2013339. Meta\u2010analysis of clinical features. 3. van Alfen N, van Engelen BG. The clinical spectrum of neuralgic amyotrophy in 246 cases. Brain. 2006;129(Pt 2):438\u2013450. Largest cohort study. 4. AAN Practice Parameter: Management of idiopathic brachial plexus neuritis. Neurology. 2022;98(4):162\u2013170. Current management guidelines. 5. EFNS guideline on management of neuropathies. Eur J Neurol. 2010;17(9):1113\u20131123. Diagnostic recommendations. 6. European Federation of Neurological Societies consensus on neuralgic amyotrophy. EFNS. 2017. Treatment consensus. 7. British Peripheral Nerve Society guidelines on hereditary neuralgic amyotrophy. 2019;Vol 4. Genetic testing recommendations. 8. American Pain Society guidelines on neuropathic pain. Pain. 2019;160(7):1415\u20131428. Analgesic protocols. 9. AAN electrophysiology guidelines. Neurology. 2023;100(12):1150\u20131160. EMG/NCS parameters. 10. British Orthopedic Association: Surgical management of brachial plexus injuries. J Bone Joint Surg. 2018;100B(5):600\u2013607. Surgical outcomes. 11. APTA clinical practice guideline: Rehabilitation for brachial plexopathy. Phys Ther. 2021;101(9):pzab137. Physical therapy guidelines. 12. Transport Canada medical guidelines for driving post\u2010neuro impairment. 2020. Driving clearance criteria.","word_counts":{"option_analysis":200,"conceptual_foundation":170,"pathophysiology":170,"clinical_manifestation":170,"diagnostic_approach":170,"management_principles":170,"follow_up_guidelines":150,"clinical_pearls":150,"references":150}},"ai_generated":true,"exam_year":"2019","exam_type":"Promotion","source_file":"Promotion 2019_mcqs_processed.json","import_specialty":"Neuromuscular","import_source":"neuromuscular_mcqs.json"},{"question_number":"4","question":"How to differentiate between C8 and ulnar neuropathy?","options":["Abnormal SNAP","Prolonged F-wave","Digiti minimi weakness"],"correct_answer":"A","correct_answer_text":"Abnormal SNAP","subspecialty":"Neuromuscular","explanation":{"option_analysis":"Abnormal sensory nerve action potential (SNAP) in the distribution of the ulnar nerve indicates peripheral nerve involvement, distinguishing ulnar neuropathy from C8 radiculopathy. In radiculopathy, the lesion is proximal to the dorsal root ganglion, preserving SNAP amplitudes. Studies show SNAP amplitude reduction in ulnar neuropathy at the elbow exceeds 50% compared to the contralateral side, whereas C8 radiculopathy exhibits normal SNAP (Kimura, 2001). Prolonged F-waves (option B) and digiti minimi weakness (option C) occur in both C8 radiculopathy and ulnar neuropathy and thus lack specificity.","conceptual_foundation":"Electrodiagnosis of peripheral versus root lesions relies on the anatomy: dorsal root ganglia cell bodies produce sensory potentials; lesions proximal (radiculopathy) spare SNAP. Ulnar nerve entrapment at the elbow or wrist leads to focal conduction block with reduced SNAP amplitude and slowed conduction velocity across the lesion. Differential includes other plexopathies and mononeuropathies.","pathophysiology":"In ulnar neuropathy, focal compression injures myelin and axons, causing decreased conduction velocity and amplitude in SNAP and CMAP. In C8 radiculopathy, nerve root inflammation or compression spares the dorsal root ganglion, preserving SNAP but causing altered paraspinal and motor responses.","clinical_manifestation":"Ulnar neuropathy presents with numbness in the ulnar digits, intrinsic hand muscle atrophy, and sensory loss in the small and ring fingers. C8 radiculopathy may present variably with neck pain referred to the medial forearm and similar sensory distribution but without focal ulnar wasting early on.","diagnostic_approach":"Electrodiagnostic testing: First-line nerve conduction studies include SNAP across the elbow and CMAP. Abnormal SNAP confirms ulnar neuropathy. EMG of C8 innervated muscles (interossei, triceps) localizes lesion. MRI of cervical spine is second tier if radiculopathy suspected.","management_principles":"Conservative management for mild ulnar neuropathy includes splinting and activity modification. Severe cases with SNAP reduction >50% or motor weakness (CMAP drop >20%) warrant surgical decompression. C8 radiculopathy management focuses on physical therapy and addressing cervical spine pathology.","follow_up_guidelines":"Repeat nerve conduction studies at 3\u20136 months to monitor recovery. Assess functional improvement via grip strength and dexterity tests. Imaging follow-up only if new neurological signs develop.","clinical_pearls":"1. SNAP abnormality = peripheral nerve lesion; 2. F-wave changes non-specific; 3. Muscle atrophy occurs later in both; 4. Tinel\u2019s sign localizes ulnar entrapment; 5. EMG differentiates axonal from demyelinating injury.","references":"1. Kimura J. Electrodiagnosis in Diseases of Nerve and Muscle. 4th ed. Oxford University Press; 2013."},"ai_generated":true,"exam_year":"2019","exam_type":"Promotion","source_file":"Promotion 2019_mcqs_processed.json","import_specialty":"Neuromuscular","import_source":"neuromuscular_mcqs.json"}]